The activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasites. by Delves, M, Plouffe, D, Scheurer, C, Meister, S, Wittlin, S, Winzeler, E, Sinden, R, Leroy, D

The 3-phosphoinositide–dependent protein kinase 1 is an essential upstream activator of protein kinase A in malaria parasites by Hitz, E, Wiedemar, N, Passecker, A, Graça, BAS, Scheurer, C, Wittlin, S, Brancucci, NMB, Vakonakis, I, Mäser, P, Voss, TS

In vitro and in vivo characterization of the antimalarial lead compound SSJ-183 in Plasmodium models by Schleiferböck S, Scheurer C, Ihara M, Itoh I, Bathurst I, Burrows JN, Fantauzzi P, Lotharius J, Charman SA, Morizzi J, Shackleford DM, White KL, Brun R, Wittlin S

Get full text

Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy Modeling. by Le Bihan, A, de Kanter, R, Angulo-Barturen, I, Binkert, C, Boss, C, Brun, R, Brunner, R, Buchmann, S, Burrows, J, Dechering, K, Delves, M, Ewerling, S, Ferrer, S, Fischli, C, Gamo-Benito, F, Gnädig, N, Heidmann, B, Jiménez-Díaz, M, Leroy, D, Martínez, M, Meyer, S, Moehrle, J, Ng, C, Noviyanti, R, Ruecker, A, Sanz, L, Sauerwein, R, Scheurer, C, Schleiferboeck, S, Sinden, R, Snyder, C, Straimer, J, Wirjanata, G, Marfurt, J, Price, R, Weller, T, Fischli, W, Fidock, D, Clozel, M, Wittlin, S